Stay updated on Nivolumab Dose Optimization Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.

Latest updates to the Nivolumab Dose Optimization Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check62 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and criteria for a clinical trial related to lung cancer, while adding a new revision number and the term 'Lung Cancer'.SummaryDifference5%
Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.